Hillsdale Investment Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
BCM
RIM
RCMC
Hillsdale Investment Management's IRMD Position: Q2 2024 in Review
Hillsdale Investment Management sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 97,400 shares — an estimated $4.28M sold.
Hillsdale Investment Management first reported a position in IRMD in Q2 2018 and held it in 13 quarters. The position peaked at $5.61M in Q4 2021. 139 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.
- Hillsdale Investment Management reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
- Hillsdale Investment Management sold 97,400 iRadimed shares in Q2 2024, an estimated $4.28M.
- Hillsdale Investment Management first reported a position in iRadimed in Q2 2018 and held it in 13 quarters.
- Hillsdale Investment Management's iRadimed position peaked at $5.61M in Q4 2021.
- 139 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.
Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.